Late-Breaking Trial session

Discussants: T. Imamura, T. Ochiai, T. Okuno, D. W. Park, S. Saito, G. Tang

Spokesperson: M. Tabata

Summary

Discover the latest insights from pivotal studies in this PCR Tokyo Valves 2025 LBT session. Explore early feasibility updates from the AltaValve trial, in-hospital outcomes comparing surgical vs. percutaneous intervention in aortic stenosis with coronary artery disease from the JROAD-DPC data, and procedural results from the M-TEER PASCAL device study. Gain insights from the LANDMARK trial on early outcomes with the latest generation TAVI valves in women, and understand the impact of basal septal bulge on conduction disturbances after TAVI. Don’t miss these essential updates!

Presentations available when logged in:

AltaValve early feasibility updates
In-hospital outcomes after surgical treatment vs. percutaneous intervention in patients with aortic stenosis concomitant coronary artery disease fr...
Procedural results and early safety of M-TEER using the PASCAL device
Early outcomes with latest generation TAVI valves in women population – Insights from LANDMARK trial
Impact of basal septal bulge on conduction disturbance after TAVI

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Late-Breaking Trial session

Log in or create account for free